- Home
- KPTI vs CPHI Comparison
KPTI vs CPHI Comparison
Compare KPTI & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | CPHI |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7M | 41.3M |
| IPO Year | 2013 | 2008 |
Fundamental Metrics
Financial Performance| Metric | KPTI | CPHI |
|---|---|---|
| Price | $0.51 | $0.65 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.25 | N/A |
| AVG Volume (30 Days) | 1.6M | ★ 3.9M |
| Earning Date | 11-06-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | $4,144,268.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $27.98 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $0.31 | $0.38 |
| 52 Week High | $10.99 | $19.19 |
Technical Indicators
Market Signals| Indicator | KPTI | CPHI |
|---|---|---|
| Relative Strength Index (RSI) | 29.67 | 42.48 |
| Support Level | $0.31 | $0.53 |
| Resistance Level | $2.16 | $0.68 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 50.74 | 3.70 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.